Any HBV trial is more than three years away. They have proved bugger all. They won't be using the vector again and the payload will be entirely new. Sugar coating the failure, complete failure, of TT won't help. This is going to go a lot lower and there will be no money from pharma. They are absolutely full of it. They have wasted fifty million dollars.
- Forums
- ASX - By Stock
- Ann: BENITEC ANNOUNCES TT-034 CLINICAL STUDY RESULTS-BLT.AX
Any HBV trial is more than three years away. They have proved...
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some